hrp0094p2-38 | Adrenals and HPA Axis | ESPE2021

Addison’s disease: Delay in diagnosis in a girl with longstanding symptoms

Vlachopapadopoulou Elpis Athina , Bonataki Myrto , Dikaiakou Eirini , Fakiolas Stefanos , Kafetzi Maria , Michalacos Stefanos ,

Background: Autoimmune destruction of the adrenal cortex is the cause of primary adrenal insufficiency in 45% to 55% of cases in children.Case presentation: A 10-year and 10-month-old female was admitted to the Pediatric Endocrinology Clinic for evaluation of suspected adrenal insufficiency. The girl reported longstanding complaints of fatigue, loss of appetite, recurrent gastric symptoms and salt craving. Medical history was significant...

hrp0098p2-41 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Linear growth in children and adolescents treated with zoledronic acid (ZA): A Single Institution Case Series

Bonataki Myrto , Doulgeraki Artemis , Papadopoulou Aikaterini-Kydonia , Polyzois Georgios , Athanasopoulou Helen , Vlachopapadopoulou Elpis-Athina

Introduction: Intravenously given bisphosphonates are the treatment of choice for pediatric osteoporosis. As bone resorption is an essential part of the normal endochondral ossification process, there were concerns on the possible negative impact of bisphosphonates on longitudinal growth during childhood. The aim of this study is to report the impact of zoledronic acid (ZA) on height in pediatric patients with primary osteoporosis.<stron...

hrp0095p2-46 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Successful treatment with zoledronic acid of a 13-year-old boy with corticosteroid-induced osteoporosis after hematopoietic stem cell transplantation

Athina Vlachopapadopoulou Elpis , Bonataki Myrto , Doulgeraki Artemis , Polyzois Giorgos , Paisiou Anna , Goussetis Eugenios , Peristeri Ioulia , Michalacos Stefanos

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) has emerged as an increasingly successful option to cure a variety of malignant disorders in children. Children benefit from improved survival; however, HSCT is associated with numerous acute and long-term toxicities. Osteoporosis is a well described, late effect of allogeneic HSCT, associated with corticosteroid treatment and patients exposed to cumulative doses >9000 mg/m2 of prednisone...